Deutsche Bank Reiterates a Buy Rating on Tenet Healthcare (THC)

In a report issued on July 25, Pito Chickering from Deutsche Bank reiterated a Buy rating on Tenet Healthcare (THCResearch Report), with a price target of $90.00. The company’s shares closed last Tuesday at $63.17.

According to, Chickering is a 2-star analyst with an average return of 0.3% and a 38.7% success rate. Chickering covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Bausch + Lomb Corporation, and Zimmer Biomet Holdings.

Currently, the analyst consensus on Tenet Healthcare is a Strong Buy with an average price target of $89.08, a 41.1% upside from current levels. In a report issued on July 11, Raymond James also maintained a Buy rating on the stock with a $110.00 price target.

See the top stocks recommended by analysts >>

The company has a one-year high of $92.65 and a one-year low of $50.37. Currently, Tenet Healthcare has an average volume of 1.79M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities. It operates through the following business segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment comprises of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes operations of USPI joint venture and the company’s nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans, and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Read More on THC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More